BVS — Bioventus Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1665988 ·
Last close
$10.60
Market Cap
$725.83M
52W High
$15.89
52W Low
$6.47
ADV30
578,703
Next earnings
2026-11-02

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 142,442,000 97,128,000 9,700,000 5,987,000 673,430,000 30,709,000 381,556,000
Jun 2026 153,208,000 105,666,000 18,712,000 33,441,000 673,346,000 29,457,000 395,934,000
Mar 2026 132,089,000 90,769,000 8,870,000 3,113,000 650,539,000 35,846,000 416,274,000
Dec 2025 157,900,000 108,782,000 21,721,000 14,755,000 683,559,000 51,238,000 455,112,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$87,433,000
Investing CF
$-5,448,000
Financing CF
$-92,606,000
CapEx
$-2,448,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.80
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-292,388,000
Inventory
$83,096,000
Receivables
$138,228,000
ST Investments
—
EBIT TTM
$57,584,000
Pretax Income TTM
$40,126,000
Interest Exp TTM
$17,458,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$585,638,976
EBITDA
$77,493,000
Free Cash Flow
$55,570,500
Enterprise Value
$989,004,480
Total Cash
$33,032,000
Total Debt
$244,150,000
Shares Out
68,474,219
Trailing EPS
$0.81
Book Value
$3.51
ROE
25.8%
ROA
5.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 568,087,000 56,291,000 22,732,000 683,559,000 455,112,000 184,105,000 74,673,000
Dec 2024 573,280,000 22,825,000 -36,125,000 727,956,000 542,352,000 147,940,000 38,795,000
Dec 2023 512,345,000 2,026,000 -156,230,000 810,910,000 589,792,000 173,591,000 15,344,000
Dec 2022 512,117,000 -34,656,000 -158,704,000 1,372,649,000 960,427,000 325,238,000 -13,537,000

TTM Snapshot

Revenues TTM
$581,848,000
NetIncome TTM
$54,464,000
OpCashFlow TTM
—
Assets (Latest)
$673,346,000
Forward EPS
$0.91

Max Pain — expiry 2027-01-15

max pain strike: $7.50 · spot: $10.62 · call oi: 1,629 · put oi: 24
Expected Move to 2027-01-15: ±$2.31 (21.75%) — implied range $8.31 – $12.93 · ATM straddle on $10.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
INMD InMode Ltd. $743.47M $12.92 —
STVN Stevanato Group S.p.A. $759.94M $15.25 —
DCTH DELCATH SYSTEMS, INC. $673.84M $19.37 —
BBNX Beta Bionics, Inc. $800.28M $14.72 —
KIDS ORTHOPEDIATRICS CORP $820.13M $31.41 —

News headlines (Yahoo Finance, 1h cache)

Bioventus (BVS) Stock Price Slides After Q3 Results Cut Revenue Outlook
2026-11-04 04:37 · Yahoo
Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset ...
2026-11-03 07:04 · Yahoo
Bioventus (BVS) Q3 2026 Earnings Call Transcript
2026-11-03 04:28 · Yahoo
Bioventus Q3 Earnings Call Highlights
2026-11-02 23:13 · Yahoo
Bioventus: Q3 Earnings Snapshot
2026-11-02 23:01 · Yahoo
Bioventus (BVS) Matches Q3 Earnings Estimates
2026-11-02 21:55 · Yahoo
Bioventus Reports Third Quarter Financial Results
2026-11-02 21:05 · Yahoo
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
2026-10-27 11:00 · Yahoo
Bioventus (BVS) Q2 2026 Earnings Call Transcript
2026-08-13 13:17 · Yahoo
Bioventus (BVS) Stock Still Looks Like A Bargain On Earnings
2026-08-10 20:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.